Attralus Alternatives & Competitors
12 companies similar to Attralus — Attralus is a biopharmaceutical company creating transformative medicines for pa...
Walden Biosciences
Transforming the Treatment of Kidney Disease
Cambridge, United States
Complement Therapeutics
Developing the next generation of complement medicines
Germany
Blueprint Medicines
Striving to improve and extend patients' lives
Cambridge, United States
-logo.jpg "Immix Biopharma (Nasdaq: IMMX)"){kind=logo}
Immix Biopharma (Nasdaq: IMMX)
Autoimmune CAR-T Clinical Trailblazer. CAR-T cell therapy for AL Amyloidosis and other aut...
Los Angeles, United State...
Track all Attralus competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
ORGENTEC Diagnostika GmbH
Specialties in Diagnostics
Mainz, Germany
Satellite Bio
Tackling some of humankind’s most elusive diseases with Tissue Therapeutics, a new categor...
Cambridge, United States
Pathalys Pharma
Our mission is to improve the lives of patients through enhanced therapeutics to advance t...
Raleigh, United States
Heartseed Inc.
Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiom...
Japan
Bluejay Therapeutics
Developing innovative cures for infectious diseases with the first target indication of ch...
United States
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune disease...
Philadelphia, United Stat...
Xeno Biosciences
Gastric Bypass in a Pill
Cambridge, United States
PhotonPharma
An immuno-oncology company unleashing the body to fight cancer
Fort Collins, United Stat...
About Attralus
Attralus is a biopharmaceutical company creating transformative medicines for patients with systemic amyloidosis.
Development of therapeutic interventions targeting amyloidosis, Pan-amyloid removal technology, Biologics and imaging agent development
Patients with systemic amyloidosis, Healthcare professionals treating amyloidosis, Pharmaceutical partners seeking novel therapies, Investors in biotech innovations
Biopharmaceutical, Systemic Amyloidosis, Transformative Medicines, PAR Therapeutics, Amyloid Removal, Disease Pathology, Peptide-based Agents, Clinical Stage, Therapeutics Development, Organ And Tissue Binding, Universal Pathology Targeting, Disease Reversal, Diagnosis And Treatment, Subtype Treatment
B2B, B2C, B2D
Product Sales, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Attralus and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Attralus on 11 Mar 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.